Invesco Nasdaq Biotechnology ETF Rating $22.41 -0.46 (-1.99%) As of 02/7/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.71Holdings in IBBQ have an aggregate rating of Moderate Buy based on 747 analyst ratings issued in the past year covering 49 companies (78.4% of the portfolio).IBBQ Aggregate Price Target$22.38High Prediction$22.38Average Prediction$22.38Low Prediction$22.38Holdings in IBBQ have an aggregate price target of $22.38 and a range of $22.38 to $22.38 covering 49 companies (78.4% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.45%GILDGilead Sciences$96.04-2.0%4.7041 of 5 stars2.70$98.39 2.4%27Positive News8.13%AMGNAmgen$293.54-1.4%4.7004 of 5 stars2.46$313.23 6.7%24Earnings ReportAnalyst Revision7.69%VRTXVertex Pharmaceuticals$469.32-2.5%3.8468 of 5 stars2.63$502.58 7.1%27Analyst RevisionPositive News7.14%REGNRegeneron Pharmaceuticals$710.00-1.7%4.9349 of 5 stars2.76$973.13 37.1%25Earnings ReportDividend AnnouncementAnalyst Revision3.86%AZNAstraZeneca$71.99-0.5%3.4178 of 5 stars3.00$89.75 24.7%9Earnings ReportDividend IncreaseAnalyst Revision3.34%ALNYAlnylam Pharmaceuticals$276.19-0.7%4.238 of 5 stars2.72$298.61 8.1%25Upcoming Earnings2.16%ILMNIllumina$111.06-9.6%4.7764 of 5 stars2.67$161.40 45.3%21Earnings ReportAnalyst ForecastGap DownHigh Trading Volume2.02%BIIBBiogen$141.35-0.7%4.7217 of 5 stars2.43$228.80 61.9%282.00%ARGXargenx$646.64-1.7%2.9095 of 5 stars2.86$658.39 1.8%22Analyst Revision1.69%SMMTSummit Therapeutics$20.11-2.7%2.1286 of 5 stars2.86$33.57 66.9%7Positive NewsGap Down1.61%UTHRUnited Therapeutics$347.71-1.7%4.4017 of 5 stars2.69$382.08 9.9%131.51%SNYSanofi$53.35+0.9%3.8086 of 5 stars3.25$60.00 12.5%4Positive News1.44%MRNAModerna$32.60-3.0%4.5573 of 5 stars2.09$67.26 106.3%231.44%NBIXNeurocrine Biosciences$122.62-18.5%4.943 of 5 stars2.86$169.20 38.0%22Earnings ReportAnalyst ForecastGap DownHigh Trading Volume1.36%INCYIncyte$74.13-1.1%4.6863 of 5 stars2.35$75.71 2.1%20Upcoming EarningsPositive News1.36%INSMInsmed$79.95-1.0%2.738 of 5 stars3.00$85.00 6.3%16Analyst ForecastInsider Trade1.31%ITCIIntra-Cellular Therapies$127.01-0.1%4.1948 of 5 stars2.53$103.62 -18.4%15Analyst Forecast1.30%RPRXRoyalty Pharma$31.73+1.1%4.6818 of 5 stars3.00$41.67 31.3%7Upcoming EarningsPositive News1.29%VTRSViatris$10.73-1.6%3.3711 of 5 stars2.00$13.67 27.4%31.15%BMRNBioMarin Pharmaceutical$63.93-0.6%4.9715 of 5 stars2.74$94.20 47.3%23Positive News1.10%BNTXBioNTech$117.61-1.9%2.1359 of 5 stars2.88$142.72 21.3%17Gap Down1.08%SRPTSarepta Therapeutics$111.82-0.3%4.729 of 5 stars2.91$178.71 59.8%221.05%PCVXVaxcyte$87.42-1.8%1.967 of 5 stars3.00$145.71 66.7%81.04%MEDPMedpace$354.10-1.9%4.2766 of 5 stars2.45$381.44 7.7%110.91%EXELExelixis$33.48-0.6%4.5383 of 5 stars2.53$36.06 7.7%19Analyst Revision0.79%ROIVRoivant Sciences$10.89+0.2%2.9968 of 5 stars3.00$17.93 64.6%80.75%TEMTempus AI$68.96+6.1%1.4443 of 5 stars2.75$58.55 -15.1%12Insider TradeGap Up0.74%ASNDAscendis Pharma A/S$120.87-3.3%3.424 of 5 stars2.93$191.57 58.5%140.71%JAZZJazz Pharmaceuticals$120.29+0.2%4.9474 of 5 stars2.87$177.00 47.1%15Positive News0.69%MDGLMadrigal Pharmaceuticals$332.72+0.7%3.5951 of 5 stars2.69$351.67 5.7%13Analyst Revision0.69%BPMCBlueprint Medicines$104.98-4.2%1.6019 of 5 stars2.65$123.72 17.9%20Analyst Revision0.68%HALOHalozyme Therapeutics$57.10-1.4%4.4149 of 5 stars2.60$60.89 6.6%10Analyst Revision0.67%RVMDRevolution Medicines$42.19-3.2%4.3979 of 5 stars3.08$66.25 57.0%12Positive News0.66%BBIOBridgeBio Pharma$31.85-2.6%4.1057 of 5 stars2.92$49.00 53.8%130.57%GHGuardant Health$44.47-3.5%3.7429 of 5 stars3.00$42.63 -4.1%16Gap DownHigh Trading Volume0.54%CYTKCytokinetics$42.76-7.4%4.2402 of 5 stars2.88$83.00 94.1%16Analyst ForecastAnalyst RevisionHigh Trading Volume0.52%NUVLNuvalent$85.68-1.2%2.4441 of 5 stars2.86$112.36 31.1%14Analyst RevisionPositive News0.50%IONSIonis Pharmaceuticals$31.40-3.8%4.1742 of 5 stars2.68$60.65 93.1%190.48%AXSMAxsome Therapeutics$105.76-3.4%4.8654 of 5 stars3.00$134.00 26.7%140.47%ALKSAlkermes$31.57+0.6%3.8222 of 5 stars2.64$36.00 14.0%110.43%KRYSKrystal Biotech$154.87-3.8%4.7604 of 5 stars3.00$206.67 33.4%80.43%SRRKScholar Rock$39.95-1.9%3.2834 of 5 stars3.14$40.43 1.2%7Positive News0.39%VRNAVerona Pharma$60.26-1.6%1.9823 of 5 stars3.13$53.14 -11.8%8Positive NewsGap Down0.39%RAREUltragenyx Pharmaceutical$45.35-0.9%4.555 of 5 stars2.93$92.43 103.8%140.38%ADMAADMA Biologics$16.71-1.2%4.025 of 5 stars3.25$21.25 27.2%40.37%APLSApellis Pharmaceuticals$29.39-2.7%4.3713 of 5 stars2.63$46.71 58.9%190.37%CRSPCRISPR Therapeutics$39.71-2.2%2.8989 of 5 stars2.50$77.59 95.4%20Analyst Revision0.35%CRNXCrinetics Pharmaceuticals$36.98-4.5%4.2213 of 5 stars2.92$72.64 96.4%12Analyst Revision0.35%RNAAvidity Biosciences$34.92-0.5%1.3158 of 5 stars3.00$65.80 88.4%10 This page (NASDAQ:IBBQ) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersJapanese billionaire pledges $500 billion to Trump’s AmericaJapanese billionaire Masayoshi Son calls it “the beginning of America’s golden age.” But I call it, “you’re...Porter & Company | SponsoredBig Tech’s $17 Trillion Reckoning DayThe world's biggest tech companies are silently sounding the alarm. While everyday investors keep piling in...InvestorPlace | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredTop 5 Trump Stocks for His First 100 DaysRight now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredSteve Bannon Sounds Alarm On Elon Musk’s ‘Indefensible Betrayal’Now, if Elon Musk was truly an America First champion… His cronies wouldn't be bragging to the New York Tim...Colonial Metals | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.